Premium
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Argatroban in Combination With A GP IIB/IIIA Antagonist in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Author(s) -
Cox D.S.,
Aluri J.,
Minthorn E.,
Holdbrook F.,
Parchman L.,
Fossler M.
Publication year - 2003
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(03)90474-7
Subject(s) - conventional pci , percutaneous coronary intervention , medicine , pharmacodynamics , argatroban , pharmacokinetics , pharmacology , antagonist , cardiology , anesthesia , myocardial infarction , receptor , platelet , thrombin
Clinical Pharmacology & Therapeutics (2003) 73 , P32–P32; doi: